Systematic Reviews
Copyright ©The Author(s) 2019.
World J Diabetes. Feb 15, 2019; 10(2): 96-113
Published online Feb 15, 2019. doi: 10.4239/wjd.v10.i2.96
Table 2 Human trials examining effects of long-term royal jelly treatment
Ref.Study designSubjectsTreatmentOutcome measuresEffectiveness
Khoshpey et al[12]Randomized double-blind controlled trialN = 11 females + 12 males aged 20-65 with type 2 diabetes in control group (placebo)3000 mg royal jelly oral capsules once per day for 8 wk. Control received placeboMacronutrient intakeNo significant change in macronutrient intake
N = 13 females + 10 males aged 20-65 with type 2 diabetes in treatment groupHyperglycemia: Fasting blood glucoseFasting blood glucose significantly reduced in comparison to control group (d = -0.87)
Mobasseri et al[28]Randomized controlled trialN = 25 + 25 females with type 2 diabetes aged 30-65 in control and treatment groups200 mg royal jelly powder prepared in gel form and served with breakfast for 8 wk. Control group received placeboPlasma triglycerideSignificantly decreased plasma triglyceride in comparison to control (d = -0.476)
Morita et al[29]Randomized double-blind controlled trialN = 30 healthy adults 42-83 yr of age in control (placebo)3000 mg royal jelly in 100 mL liquid daily for 6 mo. Control received placebo identical in appearanceBody weight: BMISignificantly improved fasting blood glucose (d = -0.9596)
N = 31 healthy adults 42-83 yr of age in treatment groupInsulin resistance: HOMA-IRNo significant changes in other outcomes of interest
Hyperglycemia: HbA1c, fasting blood glucose
Plasma triglyceride
Pourmoradian et al[13]Human double-blinded randomized clinical trialN = 23 females aged 30-65 with type 2 diabetes in treatment group1000 mg lyophilized royal jelly in soft gel form served after breakfast for 8 wk. Control group received placebo soft gelBody weight: weight scale before and after study periodSignificantly decreased body weight within same group, before and after intervention (d = -0.3808)
N = 22 females aged 30-65 with type 2 diabetes in control groupMacronutrient intake: 24-h recall food questionnaire for 3 d before and after study periodSignificantly decreased energy intake within same group, before and after intervention (d = -9.52)
Pourmoradian et al[30]Human double-blinded randomized controlled trialN = 21 females aged 30-65 with type 2 diabetes in treatment group1000 mg lyophilized royal jelly in soft gel form served after breakfast for 8 wk. Control group received placebo soft gelPlasma insulinSignificantly decreased plasma insulin and HbA1c and insignificantly decreased fasting blood glucose compared to baseline within same group, before and after intervention.
N = 20 females aged 30-65 with type 2 diabetes in control groupHbA1cd = 0.016 (HbA1c)
Hyperglycemia: Fasting blood glucosed = -0.0785 (plasma insulin)
Shidfar et al[31]Human double-blinded randomized controlled trialN = 23 + 23 adults 25-65 yr old with type 2 diabetes in experimental and control (placebo) groups1000 mg royal jelly in soft gelatin capsules 3 times daily for 8 wk. Control group received placebo identical in appearance to treatmentFasting blood sugarSignificantly decreased fasting blood levels to more normal range (d = -0.3725)
Macronutrient intake: 24-h recall diet questionnaireDid not significantly alter macronutrient intake
Insulin resistance: HOMA-IRSignificantly decreased HOMA-IR: improved insulin sensitivity (d = -0.79)